Successful treatment of high-risk acute promyelocytic leukemia in very elderly patients using all-trans retinoic acid plus reduced-dose idarubicin

Ann Hematol. 2014 Sep;93(9):1621-3. doi: 10.1007/s00277-013-1995-7. Epub 2014 Jan 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Age Factors
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Idarubicin / administration & dosage
  • Idarubicin / therapeutic use*
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Leukemia, Promyelocytic, Acute / pathology
  • Risk
  • Treatment Outcome
  • Tretinoin / administration & dosage
  • Tretinoin / therapeutic use*

Substances

  • Tretinoin
  • Idarubicin